These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. [Not Available]. Zboray B Commun Hist Artis Med Suppl; 1977; (9-10):69-83. PubMed ID: 11631149 [No Abstract] [Full Text] [Related]
55. [A facet of governmental drug administration in Japan. (Jpn)]. Nakagawa Y Igakushi Kenkyu; 1976; 47():99-106. PubMed ID: 11610550 [No Abstract] [Full Text] [Related]
56. Human rights and Mexico's antidrug campaign. Craig RB Soc Sci Q; 1980; 60(4):691-701. PubMed ID: 11630769 [No Abstract] [Full Text] [Related]
57. International control of narcotics and dangerous drugs: a synopsis. Craig RB; Turner MA Indian Pol Sci Rev; 1977; 11(1):33-47. PubMed ID: 11620193 [No Abstract] [Full Text] [Related]
58. Making governmental policy under conditions of scientific uncertainty: a century of controversy about saccharin in Congress and the laboratory. Priebe PM; Kauffman GB Minerva; 1980; 18(4):556-74. PubMed ID: 11611011 [No Abstract] [Full Text] [Related]
59. La campaña permanente: Mexico's antidrug campaign. Craig RB J Inter Am Stud World Aff; 1978; 20(2):107-131. PubMed ID: 11632266 [No Abstract] [Full Text] [Related]
60. The development of state pharmaceutical law. Cowen DL Pharm Hist; 1995; 37(2):49-58. PubMed ID: 11639644 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]